Bringing the very best science and medicine to our best equine friends
August 7, 2017

Kindred Biosciences Announces Second Quarter 2017 Financial Results

SAN FRANCISCO, Aug. 7, 2017 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the second quarter ended June 30, 2017 and provided updates on its programs. “We continue to look forward to our two upcoming approvals and launches. The commercial preparations for the launches are proceeding well and the feedback from the top opinion leaders on both of our products has been very positive,” stated Richard Chin, M.D., President and CEO of KindredBio. “We are continuing to make excellent progress across our pipeline, and are pleased to announce the completion of …

Continue Reading